T/ZNX 016-2022, 21% Spinosad and Abamectin Suspension Concentrate

Scope

Main technical content: **Item** **Indicator** **Spinosad concentration, %** 18.8–21.2 **Abamectin (B1a + B1b) concentration, %** 0.9–1.1 **α (B1a/B1b)** ≥4.0 **pH value** 6.0–9.0 **Suspension rate of spinosad, %** ≥90 **Suspension rate of abamectin (B1a + B1b), %** ≥90 **Residue after pouring test, %** ≤5.0 **Residue after washing test, %** ≤0.5 **Wet sieve test (passing through a 75μm sieve), %** ≥98 **Persistent foaming (after 1 minute), mL** ≤40 **Low-temperature stability** After cold storage, the suspension rate and wet sieve test should meet the requirements of this document. **Heat storage stability** After heat storage, the content of spinosad and abamectin should not be less than 95% of the pre-storage level, and the pH value, suspension rate, wet sieve test, and pouring test should still meet the requirements of this document. **Passed** --- **Key translation notes**: 1. Technical terms like "spinosad", "abamectin", and "pH value" are translated using their standard English names. 2. Percentages and numerical values are retained in their original format. 3. Test methods such as "wet sieve test" and "pouring test" are translated to match common industry terminology. 4. The phrase "for qualified" is translated as "passed" to convey the approval status. 5. The structure of the table is preserved for clarity, with each item listed separately.

Development Information

Related Standards